|
1
|
Glatter KA and Finkelman P: History of the
Plague: An ancient pandemic for the age of COVID-19. Am J Med.
134(176)2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zaorsky NG, Churilla TM, Egleston BL,
Fisher SG, Ridge JA, Horwitz EM and Meyer JE: Causes of death among
cancer patients. Ann Oncol. 28:400–407. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Palmieri C, Turtle L, Docherty A, Harrison
E, Drake T, Greenhalf B, Openshaw PJ, Baillie JK and Semple MG:
1670O prospective data of first 1,797 hospitalized patients with
cancer and COVID-19 derived from the COVID-19 clinical information
network and international severe acute respiratory and emerging
infections consortium, WHO coronavirus clinical characterization
consortium. Ann Oncol. 31(S992)2020.
|
|
4
|
Rüthrich MM, Giessen-Jung C, Borgmann S,
Classen AY, Dolff S, Grüner B, Hanses F, Isberner N, Köhler P,
Lanznaster J, et al: COVID-19 in cancer patients: Clinical
characteristics and outcome-an analysis of the LEOSS registry. Ann
Hematol. 100:383–393. 2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Anderson EJ, Rouphael NG, Widge AT,
Jackson LA, Roberts PC, Makhene M, Chappell JD, Denison MR, Stevens
LJ, Pruijssers AJ, et al: Safety and immunogenicity of SARS-CoV-2
mRNA-1273 vaccine in older adults. N Engl J Med. 383:2427–2438.
2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lee LYW, Cazier JB, Starkey T, Briggs SEW,
Arnold R, Bisht V, Booth S, Campton NA, Cheng VWT, Collins G, et
al: COVID-19 prevalence and mortality in patients with cancer and
the effect of primary tumour subtype and patient demographics: A
prospective cohort study. Lancet Oncol. 21:1309–1316.
2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Smith LE, Amlôt R, Weinman J, Yiend J and
Rubin GJ: A systematic review of factors affecting vaccine uptake
in young children. Vaccine. 35:6059–6069. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Jacobson RM, St Sauver JL and Finney
Rutten LJ: Vaccine Hesitancy. Mayo Clin Proc. 90:1562–1568.
2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Mărcău FC, Purec S and Niculescu G: Study
on the refusal of vaccination against COVID-19 in Romania. Vaccines
(Basel). 10(261)2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kelkar AH, Blake JA, Cherabuddi K, Cornett
H, McKee BL and Cogle CR: Vaccine enthusiasm and hesitancy in
cancer patients and the impact of a webinar. Healthcare (Basel).
9(351)2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Dror AA, Eisenbach N, Taiber S, Morozov
NG, Mizrachi M, Zigron A, Srouji S and Sela E: Vaccine hesitancy:
The next challenge in the fight against COVID-19. Eur J Epidemiol.
35:775–779. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249.
2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Joshi A, Kaur M, Kaur R, Grover A, Nash D
and El-Mohandes A: Predictors of COVID-19 vaccine acceptance,
intention, and hesitancy: A scoping review. Front Public Health.
9(698111)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Barrière J, Gal J, Hoch B, Cassuto O,
Leysalle A, Chamorey E and Borchiellini D: Acceptance of SARS-CoV-2
vaccination among French patients with cancer: A cross-sectional
survey. Ann Oncol. 32:673–674. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Villarreal-Garza C, Vaca-Cartagena BF,
Becerril-Gaitan A, Ferrigno AS, Mesa-Chavez F and Platas A and
Platas A: Attitudes and factors associated with COVID-19 vaccine
hesitancy among patients with breast cancer. JAMA Oncol.
7:1242–1244. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chan WL, Ho YT, Wong CK, Choi HC, Lam KO,
Yuen KK, Kwong D and Hung I: Acceptance of COVID-19 vaccination in
cancer patients in Hong Kong: Approaches to improve the vaccination
rate. Vaccines (Basel). 9(792)2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Garassino MC, Vyas M, de Vries EGE,
Kanesvaran R, Giuliani R and Peters S: European Society for Medical
Oncology. The ESMO call to action on COVID-19 vaccinations and
patients with cancer: Vaccinate. Monitor. Educate. Ann Oncol.
32:579–581. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
COVID 19 Up To Date https://datelazi.ro/ (accessed March 7, 2022).
|
|
19
|
Gheorghe AS, Negru ŞM, Nițipir C, Mazilu
L, Marinca M, Gafton B, Ciuleanu TE, Schenker M, Dragomir RD,
Gheorghe AD, et al: Knowledge, attitudes and practices related to
the COVID-19 outbreak among Romanian adults with cancer: A
cross-sectional national survey. ESMO Open.
6(100027)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Polack FP, Thomas SJ, Kitchin N, Absalon
J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED,
Zerbini C, et al: Safety and efficacy of the BNT162b2 mRNA Covid-19
vaccine. N Engl J Med. 383:2603–2615. 2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Radio Free Europe/Radio Liberty: Inside
Romania's Hospitals As COVID Crisis Intensifies. https://www.rferl.org/a/romania-hospitals-covid-crisis/31520509.html.
Accessed March 10, 2022.
|
|
22
|
The New York Times: Romania's underfunded
health system creaks under the pressure of the pandemic. https://www.nytimes.com/2021/10/01/world/romanias-underfunded-health-system-creaks-under-the-pressure-of-the-pandemic.html.
Accessed March 10, 2022.
|
|
23
|
de Sousa MJ, Caramujo C, Júlio N,
Magalhães JC, Basto R, Fraga T, Gomes IF, Monteiro AR, Pazos I and
Sousa G: Acceptance of SARS-CoV-2 vaccination among cancer patients
in Portugal: attitudes and associated factors. Support Care Cancer.
30:4565–4570. 2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Matovina Brko G, Popovic M, Jovic M, Radic
J, Bodlovic Kladar M, Nikolic I, Vidovic V, Kolarov Bjelobrk I,
Kukic B, Salma S, et al: COVID-19 vaccines and cancer patients:
acceptance, attitudes and safety. J BUON. 26:2183–2190.
2021.PubMed/NCBI
|
|
25
|
Gallo K, Goede A, Mura C, Abel R, Moahamed
B, Preissner S, Nahles S, Heiland M, Bourne PE, Preissner R and
Mallach M: A comparative analysis of COVID-19 vaccines based on
over 580,000 cases from the vaccination adverse event reporting
system. Vaccines (Basel). 10(408)2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Hertel M, Heiland M, Nahles S, von Laffert
M, Mura C, Bourne PE, Preissner R and Preissner S: Real-world
evidence from over one million COVID-19 vaccinations is consistent
with reactivation of the varicella-zoster virus. J Eur Acad
Dermatol Venereol. 36:1342–1348. 2022.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Monin L, Laing AG, Muñoz-Ruiz M, McKenzie
DR, Del Molino Del Barrio I, Alaguthurai T, Domingo-Vila C, Hayday
TS, Graham C, Seow J, et al: Safety and immunogenicity of one
versus two doses of the COVID-19 vaccine BNT162b2 for patients with
cancer: Interim analysis of a prospective observational study.
Lancet Oncol. 22:765–778. 2021.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Forster M, Wuerstlein R, Koenig A, Amann
N, Beyer S, Kaltofen T, Degenhardt T, Burges A, Trillsch F, Mahner
S, et al: COVID-19 vaccination in patients with breast cancer and
gynecological malignancies: A German perspective. Breast.
60:214–222. 2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Stoeklé HC, Sekkate S, Angellier E, Hervé
C and Beuzeboc P: Refusal of anti-coronavirus disease 2019
vaccination in cancer patients: Is there a difference between the
sexes? Eur J Cancer. 155:54–55. 2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Vaccination situation in Romania | Covid
vaccination (Internet). (cited Jun 30, 2022). https://vaccinare-covid.gov.ro/situatia-vaccinarii-in-romania.
|
